BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golpanian S, El-Khorazaty J, Mendizabal A, DiFede DL, Suncion VY, Karantalis V, Fishman JE, Ghersin E, Balkan W, Hare JM. Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients. J Am Coll Cardiol 2015;65:125-32. [PMID: 25593053 DOI: 10.1016/j.jacc.2014.10.040] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Chung ES, Miller L, Patel AN, Anderson RD, Mendelsohn FO, Traverse J, Silver KH, Shin J, Ewald G, Farr MJ, Anwaruddin S, Plat F, Fisher SJ, AuWerter AT, Pastore JM, Aras R, Penn MS. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial. Eur Heart J 2015;36:2228-38. [PMID: 26056125 DOI: 10.1093/eurheartj/ehv254] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 15.3] [Reference Citation Analysis]
2 Florea V, Rieger AC, Natsumeda M, Tompkins BA, Banerjee MN, Schulman IH, Premer C, Khan A, Valasaki K, Heidecker B, Mantero A, Balkan W, Mitrani RD, Hare JM. The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathy. Cardiovasc Res 2020;116:2131-41. [PMID: 32053144 DOI: 10.1093/cvr/cvaa004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Schulman IH, Balkan W, Hare JM. Mesenchymal Stem Cell Therapy for Aging Frailty. Front Nutr. 2018;5:108. [PMID: 30498696 DOI: 10.3389/fnut.2018.00108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
4 Schulman IH, Suncion V, Karantalis V, Balkan W, Hare JM; Cardiovascular Cell Therapy Research Network. Clinical research skills development program in cell-based regenerative medicine. Stem Cells Transl Med 2015;4:118-22. [PMID: 25548389 DOI: 10.5966/sctm.2014-0144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
5 Finan A, Richard S. Stimulating endogenous cardiac repair. Front Cell Dev Biol 2015;3:57. [PMID: 26484341 DOI: 10.3389/fcell.2015.00057] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
6 Turner D, Rieger AC, Balkan W, Hare JM. Clinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020;11. [PMID: 32374254 DOI: 10.5041/rmmj.10401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Bagno L, Hatzistergos KE, Balkan W, Hare JM. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. Mol Ther. 2018;26:1610-1623. [PMID: 29807782 DOI: 10.1016/j.ymthe.2018.05.009] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 23.3] [Reference Citation Analysis]
8 Kouchakian MR, Baghban N, Moniri SF, Baghban M, Bakhshalizadeh S, Najafzadeh V, Safaei Z, Izanlou S, Khoradmehr A, Nabipour I, Shirazi R, Tamadon A. The Clinical Trials of Mesenchymal Stromal Cells Therapy. Stem Cells Int 2021;2021:1634782. [PMID: 34745268 DOI: 10.1155/2021/1634782] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zaki MM, Lesha E, Said K, Kiaee K, Robinson-McCarthy L, George H, Hanna A, Appleton E, Liu S, Ng AHM, Khoshakhlagh P, Church GM. Cell therapy strategies for COVID-19: Current approaches and potential applications. Sci Adv 2021;7:eabg5995. [PMID: 34380619 DOI: 10.1126/sciadv.abg5995] [Reference Citation Analysis]
10 Ten Sande JN, Smit NW, Parvizi M, van Amersfoorth SC, Plantinga JA, van Dessel PF, de Bakker JM, Harmsen MC, Coronel R. Differential Mechanisms of Myocardial Conduction Slowing by Adipose Tissue-Derived Stromal Cells Derived from Different Species. Stem Cells Transl Med 2017;6:22-30. [PMID: 28170198 DOI: 10.5966/sctm.2015-0415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
11 Kang J, Hur J, Kang JA, Lee HS, Jung H, Choi JI, Lee H, Kim YS, Ahn Y, Kim HS. Priming mobilized peripheral blood mononuclear cells with the "activated platelet supernatant" enhances the efficacy of cell therapy for myocardial infarction of rats. Cardiovasc Ther 2016;34:245-53. [PMID: 27214098 DOI: 10.1111/1755-5922.12194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
12 Smit NW, Cócera Ortega L, Végh AMD, Meijborg VMF, Smits AM, Klerk M, Tijsen AJM, Tan HL, Goumans MHT, Boink GJJ, Coronel R. Human Cardiomyocyte Progenitor Cells in Co-culture with Rat Cardiomyocytes Form a Pro-arrhythmic Substrate: Evidence for Two Different Arrhythmogenic Mechanisms. Front Physiol 2017;8:797. [PMID: 29075204 DOI: 10.3389/fphys.2017.00797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Crespo-Diaz R, Yamada S, Bartunek J, Perez-Terzic C, de Waele P, Mauën S, Terzic A, Behfar A. Cardiopoietic index predicts heart repair fitness of patient-derived stem cells. Biomark Med 2015;9:639-49. [PMID: 26014833 DOI: 10.2217/bmm.15.31] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
14 Sato Y, Kuragaichi T, Saga S, Nakayama H, Obata T, Watanabe M, Fujikura K, Watanabe M, Hata KI, Ohgushi H. Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction. Circ Rep 2021;3:550-4. [PMID: 34568634 DOI: 10.1253/circrep.CR-21-0091] [Reference Citation Analysis]
15 Rurali E, Bassetti B, Perrucci GL, Zanobini M, Malafronte C, Achilli F, Gambini E. BM ageing: Implication for cell therapy with EPCs. Mech Ageing Dev. 2016;159:4-13. [PMID: 27045606 DOI: 10.1016/j.mad.2016.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
16 Dolati S, Yousefi M, Mahdipour M, Afrasiabi Rad A, Pishgahi A, Nouri M, Jodati AR. Mesenchymal stem cell and bone marrow mononuclear cell therapy for cardiomyopathy: From bench to bedside. J Cell Biochem 2019;120:45-55. [DOI: 10.1002/jcb.27531] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Hatzistergos KE, Hare JM. Cell Therapy: Targeting Endogenous Repair Versus Remuscularization. Circ Res 2015;117:659-61. [PMID: 26405181 DOI: 10.1161/CIRCRESAHA.115.307346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang C, Li J, Zhang B, Li Y. Safety and efficacy of bone marrow-derived cells therapy on cardiomyopathy: a meta-analysis. Stem Cell Res Ther 2019;10:137. [PMID: 31109372 DOI: 10.1186/s13287-019-1238-5] [Reference Citation Analysis]
19 Cun X, Hosta-Rigau L. Topography: A Biophysical Approach to Direct the Fate of Mesenchymal Stem Cells in Tissue Engineering Applications. Nanomaterials (Basel) 2020;10:E2070. [PMID: 33092104 DOI: 10.3390/nano10102070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
20 Zhang Y, Zhu W, He H, Fan B, Deng R, Hong Y, Liang X, Zhao H, Li X, Zhang F. Macrophage migration inhibitory factor rejuvenates aged human mesenchymal stem cells and improves myocardial repair. Aging (Albany NY) 2019;11:12641-60. [PMID: 31881006 DOI: 10.18632/aging.102592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
21 Forsberg MH, Kink JA, Hematti P, Capitini CM. Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol 2020;8:665. [PMID: 32766255 DOI: 10.3389/fcell.2020.00665] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
22 Lerrer S, Liubomirski Y, Bott A, Abnaof K, Oren N, Yousaf A, Körner C, Meshel T, Wiemann S, Ben-Baruch A. Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells. Front Immunol 2017;8:479. [PMID: 28553282 DOI: 10.3389/fimmu.2017.00479] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
23 Lipinski MJ, Luger D, Epstein SE. Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications. Handb Exp Pharmacol. 2017;243:329-353. [PMID: 28382469 DOI: 10.1007/164_2017_23] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
24 Banerjee MN, Bolli R, Hare JM. Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions. Circ Res 2018;123:266-87. [PMID: 29976692 DOI: 10.1161/CIRCRESAHA.118.311217] [Cited by in Crossref: 71] [Cited by in F6Publishing: 43] [Article Influence: 23.7] [Reference Citation Analysis]
25 Schulman IH, Balkan W, Saltzman R, Dafonseca D, Caceres LV, Delgado C, Pujol MV, Ramdas KN, Tovar J, Vidro-casiano M, Hare JM. Unique Aspects of the Design of Phase I/II Clinical Trials of Stem Cell Therapy. In: Abdeldayem H, editor. The Management of Clinical Trials. InTech; 2018. [DOI: 10.5772/intechopen.72949] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Dong M, Yang Z, Fang H, Xiang J, Xu C, Zhou Y, Wu Q, Liu J. Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction. Aging Dis 2020;11:365-76. [PMID: 32257547 DOI: 10.14336/AD.2019.0522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci 2017;72:1505-12. [PMID: 28444181 DOI: 10.1093/gerona/glx056] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
28 Maillot C, Sion C, De Isla N, Toye D, Olmos E. Quality by design to define critical process parameters for mesenchymal stem cell expansion. Biotechnol Adv 2021;50:107765. [PMID: 33961977 DOI: 10.1016/j.biotechadv.2021.107765] [Reference Citation Analysis]
29 Schimke MM, Marozin S, Lepperdinger G. Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy. Front Physiol 2015;6:362. [PMID: 26696897 DOI: 10.3389/fphys.2015.00362] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
30 Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116:1413-1430. [PMID: 25858066 DOI: 10.1161/circresaha.116.303614] [Cited by in Crossref: 256] [Cited by in F6Publishing: 167] [Article Influence: 36.6] [Reference Citation Analysis]
31 Dai R, Hang Y, Liu Q, Zhang S, Wang L, Pan Y, Chen H. Improved neural differentiation of stem cells mediated by magnetic nanoparticle-based biophysical stimulation. J Mater Chem B 2019;7:4161-8. [DOI: 10.1039/c9tb00678h] [Cited by in Crossref: 13] [Article Influence: 4.3] [Reference Citation Analysis]
32 Wang J, Chen Z, Sun M, Xu H, Gao Y, Liu J, Li M. Characterization and therapeutic applications of mesenchymal stem cells for regenerative medicine. Tissue Cell. 2020;64:101330. [PMID: 32473704 DOI: 10.1016/j.tice.2020.101330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
33 Cao XK, Li R, Sun W, Ge Y, Liu BL. Co-combination of islets with bone marrow mesenchymal stem cells promotes angiogenesis. Biomed Pharmacother. 2016;78:156-164. [PMID: 26898437 DOI: 10.1016/j.biopha.2016.01.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
34 Fuster V. Editor-in-Chief's Top Picks From 2015: Part One. J Am Coll Cardiol 2016;67:687-711. [PMID: 26868695 DOI: 10.1016/j.jacc.2015.12.002] [Reference Citation Analysis]
35 Venosa A. Senescence in Pulmonary Fibrosis: Between Aging and Exposure. Front Med (Lausanne) 2020;7:606462. [PMID: 33282895 DOI: 10.3389/fmed.2020.606462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev 2016;96:1127-68. [PMID: 27335447 DOI: 10.1152/physrev.00019.2015] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 32.2] [Reference Citation Analysis]
37 Amato G, Romano G, Puleio R, Agrusa A, Goetze T, Gulotta E, Gordini L, Erdas E, Calò P. Neomyogenesis in 3D Dynamic Responsive Prosthesis for Inguinal Hernia Repair: Inguinal Hernia Repair. Artif Organs 2018;42:1216-23. [DOI: 10.1111/aor.13286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 Qin X, Han D, Wu JC. Molecular imaging of cardiac regenerative medicine. Current Opinion in Biomedical Engineering 2019;9:66-73. [DOI: 10.1016/j.cobme.2019.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
39 Iaconetti C, Sorrentino S, De Rosa S, Indolfi C. Exosomal miRNAs in Heart Disease. Physiology (Bethesda) 2016;31:16-24. [PMID: 26661525 DOI: 10.1152/physiol.00029.2015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
40 Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. Int J Mol Sci 2021;22:E763. [PMID: 33466583 DOI: 10.3390/ijms22020763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
41 Lemcke H, Voronina N, Steinhoff G, David R. Recent Progress in Stem Cell Modification for Cardiac Regeneration. Stem Cells Int 2018;2018:1909346. [PMID: 29535769 DOI: 10.1155/2018/1909346] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
42 Goto T, Miyagawa S, Tamai K, Matsuura R, Kido T, Kuratani T, Shimamura K, Sakaniwa R, Harada A, Sawa Y. High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells. PLoS One 2020;15:e0230392. [PMID: 32275672 DOI: 10.1371/journal.pone.0230392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Verhaar MC. Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy. Cell Transplant 2018;27:765-85. [PMID: 29895169 DOI: 10.1177/0963689717738257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
44 Das S, Nam H, Jang J. 3D bioprinting of stem cell-laden cardiac patch: A promising alternative for myocardial repair. APL Bioeng 2021;5:031508. [PMID: 34368602 DOI: 10.1063/5.0030353] [Reference Citation Analysis]
45 Behfar A, Terzic A. Stem cells versus senescence: the yin and yang of cardiac health. J Am Coll Cardiol 2015;65:148-50. [PMID: 25593055 DOI: 10.1016/j.jacc.2014.10.041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
46 Heathman TR, Stolzing A, Fabian C, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ. Serum-free process development: improving the yield and consistency of human mesenchymal stromal cell production. Cytotherapy 2015;17:1524-35. [PMID: 26432558 DOI: 10.1016/j.jcyt.2015.08.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
47 Xu J, Qian H, Huang P, Xu J, Xiong Y, Jiang W, Xu Y, Leng W, Li X, Chen G, Tang R, Huang C, Hu M, Jin C, Wu Y, Zhang J, Qian J, Xu B, Zhao S, Lu M, Shen R, Fang W, Wu W, Chen X, Wang Y, Li W, Lu X, Jiang X, Ma C, Li J, Geng Y, Qiao S, Gao R, Yang Y. Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial. Regenerative Medicine 2019;14:1077-87. [DOI: 10.2217/rme-2019-0024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
48 Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell 2021;28:1708-25. [PMID: 34624232 DOI: 10.1016/j.stem.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Qin X, Chen IY, Wu JC. Imaging Cardiac Stem Cell Therapy. In: Ieda M, Zimmermann W, editors. Cardiac Regeneration. Cham: Springer International Publishing; 2017. pp. 241-58. [DOI: 10.1007/978-3-319-56106-6_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Sterner RM, Sterner RC, Brenes-Salazar JA, Yu Ballard AC. Cellular therapies for chronic ischemic heart failure. Hellenic J Cardiol 2018;59:78-90. [PMID: 29355725 DOI: 10.1016/j.hjc.2018.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
51 Parashurama N, Ahn BC, Ziv K, Ito K, Paulmurugan R, Willmann JK, Chung J, Ikeno F, Swanson JC, Merk DR, Lyons JK, Yerushalmi D, Teramoto T, Kosuge H, Dao CN, Ray P, Patel M, Chang YF, Mahmoudi M, Cohen JE, Goldstone AB, Habte F, Bhaumik S, Yaghoubi S, Robbins RC, Dash R, Yang PC, Brinton TJ, Yock PG, McConnell MV, Gambhir SS. Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction. Radiology 2016;280:815-25. [PMID: 27308957 DOI: 10.1148/radiol.2016140049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
52 Rosenblatt-Velin N, Badoux S, Liaudet L. Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? Stem Cells Int 2016;2016:5961342. [PMID: 26880973 DOI: 10.1155/2016/5961342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
53 Van Pham P. Mesenchymal Stem Cells in Clinical Applications. In: Pham PV, editor. Stem Cell Processing. Cham: Springer International Publishing; 2016. pp. 37-69. [DOI: 10.1007/978-3-319-40073-0_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Hariharan N, Sussman MA. Cardiac aging - Getting to the stem of the problem. J Mol Cell Cardiol 2015;83:32-6. [PMID: 25886698 DOI: 10.1016/j.yjmcc.2015.04.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
55 Mahindran E, Law JX, Ng MH, Nordin F. Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty. Int J Mol Sci 2021;22:10542. [PMID: 34638883 DOI: 10.3390/ijms221910542] [Reference Citation Analysis]